No black box warning on record for Cisplatin

As of the latest FDA labeling reviewed, Cisplatin (CISPLATIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cisplatin medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Cisplatin produces cumulative nephrotoxicity which is potentiated by aminoglycoside antibiotics. The serum creatinine, blood urea nitrogen (BUN), creatinine clearance, and magnesium, sodium, potassium, and calcium levels should be measured prior to initiating therapy, and prior to each subsequent course. At the recommended dosage, cisplatin should not be given more frequently than once ev

No black box warning on record for Cisplatin

Other warnings & precautions

WARNINGS Cisplatin produces cumulative nephrotoxicity which is potentiated by aminoglycoside antibiotics. The serum creatinine, blood urea nitrogen (BUN), creatinine clearance, and magnesium, sodium, potassium, and calcium levels should be measured prior to initiating therapy, and prior to each subsequent course. At the recommended dosage, cisplatin should not be given more frequently than once ev

Cisplatin Black Box Warning

No black box warning on record for Cisplatin

Other warnings & precautions

Cisplatin Black Box Warning

No black box warning on record for Cisplatin

Other warnings & precautions